[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100579365":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":30,"centralContacts":38,"locations":44,"responsibleParty":56,"collaborators":30,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":30,"maxAge":30,"enrollmentInfo":70,"targetDuration":30,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":80,"overallStatus":46,"whyStopped":30,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Aswan University Hospital","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Dexmedetomidine","ACTIVE_COMPARATOR","the investigators give 5 mic of dexmedetomidine (0.5 ml) added to 2.5 mg bupivacaine (0.5 ml) as total volume 1 ml intrathecally",[13],"Drug: Dexmedetomidine",{"label":15,"type":10,"description":16,"interventionNames":17},"fentanyl","the investigators give 25 mic of fentanyl (0.5 ml) added to 2.5 mg bupivacaine (0.5 ml) as total volume 1 ml intrathecally",[18],"Drug: fentanyl",{"label":20,"type":21,"description":22,"interventionNames":23},"Bupivacaine only","PLACEBO_COMPARATOR","the investigators give 0.5 ml saline 0.9% added to 2.5 mg of bupivacaine (0.5 ml) as total volume 1 ml intrathecally",[24],"Drug: Saline 0.9%",[26,31,34],{"type":27,"name":9,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","5 mic dexmedetomidine will be given intrathecally added to 2.5 mg bupivacaine",[9],null,{"type":27,"name":15,"description":32,"armGroupLabels":33,"otherNames":30},"25 mic of fentanyl will be given intrathecally added to 2.5 mg bupivacaine",[15],{"type":27,"name":35,"description":36,"armGroupLabels":37,"otherNames":30},"Saline 0.9%","0.5 ml of saline 0.9% will be given intrathecally added to 2.5 mg of bupivacaine",[20],[39],{"name":40,"role":41,"phone":42,"phoneExt":30,"email":43},"Jehan G Younan, resident doctor.","CONTACT","+20 01222333194","jehan.younan1995@gmail.com",[45],{"facility":5,"status":46,"city":47,"state":30,"zip":30,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":30},"RECRUITING","Aswān","Egypt","EG",{"type":51,"coordinates":52},"Point",[53,54],32.89942,24.09082,{"lat":54,"lon":53},{"type":57,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"SPONSOR_INVESTIGATOR","Jehan George Sadek","resident doctor at anesthesia, surgical intensive care unit and pain management department at Aswan University hospital.","100579365","phase-4-comparative-analysis-of-analgesic-efficacy-by-single-shot-intrathecal-analgesia-sssa-in-normal-labor-100579365",false,"NCT06823349","Comparative Analysis of Analgesic Efficacy: by Single Shot Intrathecal Analgesia (SSSA) in Normal Labor","Comparative Analysis of Analgesic Efficacy and Maternal Satisfaction: Single Shot Intrathecal Bupivacaine With Fentanyl Versus Bupivacaine With Dexmedetomidine in Normal Labor, Randomized Control Clinical Trial","SSSA","Inclusion Criteria:\n\n* ASA I-II.\n* Uncomplicated pregnancy.\n* At term \\& singleton fetus.\n* Cervical dilatation \\> 5cm\n* Cephalic presentations\n\nExclusion Criteria:\n\n* Patient refusal.\n* Bleeding disorders and patients on anticoagulant drugs.\n* Infection at site of injection.\n* Spine deformity.\n* Allergy to any of study medications.",true,"FEMALE",{"count":71,"type":72},90,"ESTIMATED","INTERVENTIONAL",[75],"PHASE4","the goal of this randomized control trial is to compare the effect of adding fentanyl v.s dexmedetomidine to bupivacaine in single shot spinal analgesia in achievement of analgesia by decreasing visual analogue scale, onset and increasing duration of analgesia in normal labor.",[78,79],"Vaginal Delivery","Normal Labor",[81,82],"painless normal labor","Single shot spinal analgesia in vaginal delivery","2025-07-29",{"date":85,"type":86},"2025-07-31","ACTUAL",{"date":88,"type":86},"2025-02-01",{"date":85,"type":72},{"name":58,"class":6},1]